1
|
Lima Dos Santos CC, Matharoo AS, Pinzón Cueva E, Amin U, Perez Ramos AA, Mann NK, Maheen S, Butchireddy J, Falki VB, Itrat A, Rajkumar N, Zia Ul Haq M. The Influence of Sex, Age, and Race on Coronary Artery Disease: A Narrative Review. Cureus 2023; 15:e47799. [PMID: 38021526 PMCID: PMC10676710 DOI: 10.7759/cureus.47799] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/27/2023] [Indexed: 12/01/2023] Open
Abstract
Cardiovascular disease has remained one of the leading causes of mortality in the world. The basic pathophysiology of coronary artery disease (CAD) is a reduction of the blood flow in coronary vessels, leading to restricted blood flow to the heart muscle. Both modifiable and non-modifiable risk factors contribute to its multifactorial etiology. The clinical presentation ranges from asymptomatic to typical symptoms like chest pain, shortness of breath, and left arm or jaw pain. The purpose of this review is to investigate and analyze the variation of CAD depending on the biological sex, age, race, or ethnicity and how it might differ in the studied population while comparing the symptoms and prognosis of CAD. For this research, PubMed's database was used. A total of 926 articles were selected using pre-determined inclusion and exclusion criteria, with 74 articles eligible to be included in the narrative review. Studies were selected from the general population of patients with CAD, regardless of their severity, stage of diagnosis, and treatment plan. The scale for the assessment of non-systematic review articles (SANRA) was used to assess the quality of the study. As humans age, the incidence of CAD increases, and people over 75 are more likely to have multiple-vessel CAD. It has been observed that South Asians have the highest rate of CAD at 24%, while the White population has the lowest at 8%. The prevalence of CAD also depends on race, with the White population having the lowest rate at 3.2%, followed by Hispanics at 5%, Black women at 5.2%, and Black men at 5.7%. Younger Black women tend to have more chest pain. Men with CAD commonly experience chest pain, and women are more likely to present with atypical symptoms. Modifiable risk factors such as smoking and alcoholism are more commonly observed in young men than in young women. Coronary artery disease in the elderly, female, minority, and Black patients is associated with a higher mortality rate. Acknowledging the prevalence of certain risk factors, signs, results, and responses to treatment in certain socio-demographic groups, as well as the provision and accessibility of diagnosis and treatment, would lead to a better outcome for all individuals. The impact of this shift can range from an earlier diagnosis of CAD to a faster and more customized treatment plan tailored to each patient's individual requirements.
Collapse
Affiliation(s)
| | | | | | - Uzma Amin
- Pathology, Rawalpindi Medical University, Rawalpindi, PAK
| | | | - Navpreet K Mann
- Cardiology, Government Medical College and Rajindra Hospital, Patiala, IND
| | - Sara Maheen
- General Medicine, Odessa National Medical University, Odessa, UKR
| | - Jyothsna Butchireddy
- Cardiology, Government Medical College, Omandurar Government Estate, Chennai, IND
| | | | - Abeeha Itrat
- Cardiology, Lutheran General Hospital, Illinois, USA
| | | | - Muhammad Zia Ul Haq
- Epidemiology and Public Health, Emory University Rollins School of Public Health, Atlanta, USA
- Noncommunicable Diseases and Mental Health, World Health Organization, Cairo, EGY
| |
Collapse
|
2
|
Hammami R, Boudiche S, Rami T, Ben Halima N, Jamel A, Rekik B, Gribaa R, Imtinene BM, Charfeddine S, Ellouze T, Bahloul A, Hédi BS, Langar J, Ben Ahmed H, Ibn Elhadj Z, Hmam M, Ben Abdessalem MA, Maaoui S, Fennira S, Lobna L, Hassine M, Ouanes S, Mohamed Faouzi D, Mallek S, Mahdhaoui A, Meriem D, Jomaa W, Zayed S, Kateb T, Bouchahda N, Azaiez F, Ben Salem H, Marouen M, Noamen A, Abdesselem S, Hichem D, Ibn Hadj Amor H, Abdeljelil F, Amara A, Bejar K, Khaldoun BH, Hamza C, Ben Jamaa M, Fourati S, Elleuch F, Grati Z, Chtourou S, Marouene S, Sahnoun M, Hadrich M, Mohamed Abdelkader M, Bouraoui H, Kamoun K, Hadrich M, Ben Chedli T, Drissa MA, Charfeddine H, Saadaoui N, Achraf G, Ahmed S, Ayari M, Nabil M, Mnif S, Sahnoun M, Kammoun H, Ben Jemaa K, Mostari G, Hamrouni N, Yamen M, Ellouz Y, Smiri Z, Hdiji A, Bassem J, Ayadi W, Zouari A, Abbassi C, Fatma BM, Battikh K, Kharrat E, Gtif I, Sami M, Bezdah L, Kachboura S, Maatouk MF, Kraiem S, Jeridi G, Neffati E, Kammoun S, Ben Ameur Y, Fehri W, Gamra H, Zakhama L, Addad F, Mohamed Sami M, Abid L. Design and Rationale of the National Tunisian Registry of Percutaneous Coronary Intervention: Protocol for a Prospective Multicenter Observational Study. JMIR Res Protoc 2022; 11:e24595. [PMID: 35930353 PMCID: PMC9391981 DOI: 10.2196/24595] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2020] [Revised: 07/25/2021] [Accepted: 10/12/2021] [Indexed: 11/25/2022] Open
Abstract
Background Coronary artery diseases remain the leading cause of death in the world. The management of this condition has improved remarkably in the recent years owing to the development of new technical tools and multicentric registries. Objective The aim of this study is to investigate the in-hospital and 1-year clinical outcomes of patients treated with percutaneous coronary intervention (PCI) in Tunisia. Methods We will conduct a prospective multicentric observational study with patients older than 18 years who underwent PCI between January 31, 2020 and June 30, 2020. The primary end point is the occurrence of a major adverse cardiovascular event, defined as cardiovascular death, myocardial infarction, cerebrovascular accident, or target vessel revascularization with either repeat PCI or coronary artery bypass grafting (CABG). The secondary end points are procedural success rate, stent thrombosis, and the rate of redo PCI/CABG for in-stent restenosis. Results In this study, the demographic profile and the general risk profile of Tunisian patients who underwent PCI and their end points will be analyzed. The complexity level of the procedures and the left main occlusion, bifurcation occlusion, and chronic total occlusion PCI will be analyzed, and immediate as well as long-term results will be determined. The National Tunisian Registry of PCI (NATURE-PCI) will be the first national multicentric registry of angioplasty in Africa. For this study, the institutional ethical committee approval was obtained (0223/2020). This trial consists of 97 cardiologists and 2498 patients who have undergone PCI with a 1-year follow-up period. Twenty-eight catheterization laboratories from both public (15 laboratories) and private (13 laboratories) sectors will enroll patients after receiving informed consent. Of the 2498 patients, 1897 (75.9%) are managed in the public sector and 601 (24.1%) are managed in the private sector. The COVID-19 pandemic started in Tunisia in March 2020; 719 patients (31.9%) were included before the COVID-19 pandemic and 1779 (60.1%) during the pandemic. The inclusion of patients has been finished, and we expect to publish the results by the end of 2022. Conclusions This study would add data and provide a valuable opportunity for real-world clinical epidemiology and practice in the field of interventional cardiology in Tunisia with insights into the uptake of PCI in this limited-income region. Trial Registration Clinicaltrials.gov NCT04219761; https://clinicaltrials.gov/ct2/show/NCT04219761 International Registered Report Identifier (IRRID) RR1-10.2196/24595
Collapse
Affiliation(s)
- Rania Hammami
- Department of Cardiology, Hédi Chaker Hospital, Faculty of Medicine of Sfax, University of Sfax, Sfax, Tunisia
| | - Selim Boudiche
- Department of Cardiology, La Rabta Hospital, Faculty of Medicine of Tunis, University of Tunis, Tunis, Tunisia
| | - Tlili Rami
- Department of Cardiology, Mongi Slim Hospital, Faculty of Medicine of Tunis, University of Tunis, Tunis, Tunisia
| | - Nejeh Ben Halima
- Department of Cardiology, Kairouan Hospital, Faculty of Medicine of Sousse, University of Sousse, Kairouan, Tunisia
| | - Ahmed Jamel
- Department of Cardiology, Kairouan Hospital, Faculty of Medicine of Sousse, University of Sousse, Kairouan, Tunisia
| | - Bassem Rekik
- Department of Cardiology, La Rabta Hospital, Faculty of Medicine of Tunis, University of Tunis, Tunis, Tunisia
| | - Rym Gribaa
- Department of Cardiology, Sahloul Hospital, Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia
| | - Ben Mrad Imtinene
- Department of Cardiology, Habib Thameur Hospital, Faculty of Medicine of Tunis, University of Tunis, Tunis, Tunisia
| | - Salma Charfeddine
- Department of Cardiology, Hédi Chaker Hospital, Faculty of Medicine of Sfax, University of Sfax, Sfax, Tunisia
| | - Tarek Ellouze
- Department of Cardiology, Hédi Chaker Hospital, Faculty of Medicine of Sfax, University of Sfax, Sfax, Tunisia
| | - Amine Bahloul
- Department of Cardiology, Hédi Chaker Hospital, Faculty of Medicine of Sfax, University of Sfax, Sfax, Tunisia
| | - Ben Slima Hédi
- Department of Cardiology, Menzel Bourguiba Hospital, Faculty of Medicine of Tunis, University of Tunis, Bizerte, Tunisia
| | | | - Habib Ben Ahmed
- Department of Cardiology, Charle Nicole Hospital, Faculty of Medicine of Tunis, University of Tunis, Tunis, Tunisia
| | - Zied Ibn Elhadj
- Department of Cardiology, Abderrahmen Mami-Ariana Hospital, Faculty of Medicine of Tunis, University of Tunis, Ariana, Tunisia
| | | | - Mohamed Aymen Ben Abdessalem
- Department of Cardiology, Farhat Hached Hospital, Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia
| | | | - Sana Fennira
- Department of Cardiology, Habib Thameur Hospital, Faculty of Medicine of Tunis, University of Tunis, Tunis, Tunisia
| | - Laroussi Lobna
- Department of Cardiology, Abderrahmen Mami-Ariana Hospital, Faculty of Medicine of Tunis, University of Tunis, Ariana, Tunisia
| | - Majed Hassine
- Department of Cardiology A, Fattouma Bourguiba University Hospital, Faculty of Medicine of Monastir, University of Monastir, Monastir, Tunisia
| | - Sami Ouanes
- Department of Cardiology A, Fattouma Bourguiba University Hospital, Faculty of Medicine of Monastir, University of Monastir, Monastir, Tunisia
| | | | - Souad Mallek
- Department of Cardiology, Hédi Chaker Hospital, Faculty of Medicine of Sfax, University of Sfax, Sfax, Tunisia
| | - Abdallah Mahdhaoui
- Department of Cardiology, Farhat Hached Hospital, Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia
| | - Dghim Meriem
- Department of Cardiology, The Main Military Instruction Hospital of Tunis, Faculty of Medicine of Tunis, University of Tunis, Tunis, Tunisia
| | - Walid Jomaa
- Department of Cardiology B, Fattouma Bourguiba University Hospital, Faculty of Medicine of Monastir, University of Monastir, Monastir, Tunisia
| | - Sofien Zayed
- Department of Cardiology, Mongi Slim Hospital, Faculty of Medicine of Tunis, University of Tunis, Tunis, Tunisia
| | | | - Nidhal Bouchahda
- Department of Cardiology A, Fattouma Bourguiba University Hospital, Faculty of Medicine of Monastir, University of Monastir, Monastir, Tunisia
| | - Fares Azaiez
- Department of Cardiology, Mongi Slim Hospital, Faculty of Medicine of Tunis, University of Tunis, Tunis, Tunisia
| | | | | | - Aymen Noamen
- Department of Cardiology, The Main Military Instruction Hospital of Tunis, Faculty of Medicine of Tunis, University of Tunis, Tunis, Tunisia
| | | | - Denguir Hichem
- Department of Cardiology, Gabes Hospital, Faculty of Medicine of Sfax, University of Sfax, Gabes, Tunisia
| | - Hassen Ibn Hadj Amor
- Department of Cardiology, Habib Bourguiba Hospital, Faculty of Medicine of Sfax, University of Sfax, Medenine, Tunisia
| | - Farhati Abdeljelil
- Department of Cardiology, La Rabta Hospital, Faculty of Medicine of Tunis, University of Tunis, Tunis, Tunisia
| | | | - Karim Bejar
- Cardiologist, Private Sector, Nabeul, Tunisia
| | - Ben Hamda Khaldoun
- Department of Cardiology B, Fattouma Bourguiba University Hospital, Faculty of Medicine of Monastir, University of Monastir, Monastir, Tunisia
| | | | | | | | | | | | | | | | | | | | | | - Hatem Bouraoui
- Department of Cardiology, Farhat Hached Hospital, Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Imen Gtif
- Department of Cardiology, The Main Military Instruction Hospital of Tunis, Faculty of Medicine of Tunis, University of Tunis, Tunis, Tunisia
| | - Milouchi Sami
- Department of Cardiology, Habib Bourguiba Hospital, Faculty of Medicine of Sfax, University of Sfax, Medenine, Tunisia
| | - Leila Bezdah
- Department of Cardiology, Charle Nicole Hospital, Faculty of Medicine of Tunis, University of Tunis, Tunis, Tunisia
| | - Salem Kachboura
- Department of Cardiology, Farhat Hached Hospital, Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia
| | - Mohamed Faouzi Maatouk
- Department of Cardiology B, Fattouma Bourguiba University Hospital, Faculty of Medicine of Monastir, University of Monastir, Monastir, Tunisia
| | - Sondes Kraiem
- Department of Cardiology, Habib Thameur Hospital, Faculty of Medicine of Tunis, University of Tunis, Tunis, Tunisia
| | - Gouider Jeridi
- Department of Cardiology, Farhat Hached Hospital, Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia
| | - Elyes Neffati
- Department of Cardiology, Sahloul Hospital, Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia
| | - Samir Kammoun
- Department of Cardiology, Hédi Chaker Hospital, Faculty of Medicine of Sfax, University of Sfax, Sfax, Tunisia
| | - Youssef Ben Ameur
- Department of Cardiology, Mongi Slim Hospital, Faculty of Medicine of Tunis, University of Tunis, Tunis, Tunisia
| | - Wafa Fehri
- Department of Cardiology, The Main Military Instruction Hospital of Tunis, Faculty of Medicine of Tunis, University of Tunis, Tunis, Tunisia
| | - Habib Gamra
- Department of Cardiology A, Fattouma Bourguiba University Hospital, Faculty of Medicine of Monastir, University of Monastir, Monastir, Tunisia
| | - Lilia Zakhama
- Department of Cardiology, The Main Military Instruction Hospital of Tunis, Faculty of Medicine of Tunis, University of Tunis, Tunis, Tunisia
| | - Faouzi Addad
- Department of Cardiology, Abderrahmen Mami-Ariana Hospital, Faculty of Medicine of Tunis, University of Tunis, Ariana, Tunisia
| | - Mourali Mohamed Sami
- Department of Cardiology, La Rabta Hospital, Faculty of Medicine of Tunis, University of Tunis, Tunis, Tunisia
| | - Leila Abid
- Department of Cardiology, Hédi Chaker Hospital, Faculty of Medicine of Sfax, University of Sfax, Sfax, Tunisia
| |
Collapse
|
4
|
Nissen L, Winther S, Schmidt M, Rønnow Sand NP, Urbonaviciene G, Zelechowski MW, Christensen MK, Busk M, Lambrechtsen J, Diederichsen A, Elpert FP, Grove EL, Bøtker HE, Bøttcher M. Implementation of coronary computed tomography angiography as nationally recommended first-line test in patients with suspected chronic coronary syndrome: impact on the use of invasive coronary angiography and revascularization. Eur Heart J Cardiovasc Imaging 2020; 21:1353-1362. [PMID: 32888290 DOI: 10.1093/ehjci/jeaa197] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/24/2020] [Accepted: 06/16/2020] [Indexed: 01/07/2023] Open
Abstract
AIMS To investigate the impact of applying coronary computed tomography angiography (CCTA), as the recommended first-line diagnostic test in patients with suspected chronic coronary syndrome (CCS) on the use of invasive coronary angiography (ICA) and revascularization practice. METHODS AND RESULTS We included all patients undergoing a first-time CCTA (n = 53555) and first-time ICA (n = 41451) from 2008 to 2017 due to suspected CCS in Western Denmark (3.3 million inhabitants). The number of CCTA procedures increased from 352 (2008) to 7739 (2017) (2098%), ICA examinations declined from 4538 to 3766 (17%). The average proportion of no- or non-obstructive coronary artery disease by CCTA was 77.5%. Referral to ICA after CCTA occurred in 16.9% of patients in 2008-10 vs. 13.9% in 2014-17 (P < 0.0001). Revascularization in patients referred to ICA after CCTA increased from 33.8% in 2008-10 vs. 44.4% in 2014-17 (P < 0.0001). The revascularization proportion in patients undergoing ICA with no preceding CCTA was 32.3% in 2008-10 vs. 33.3% in (2014-17) (P = 0.1063). Stratified by age, the overall revascularization proportion increased in the younger age groups and was unchanged or decreased in older age groups: <50 years: 60% increase, 50-59 years: 33% increase, 60-69 years: 0%, and >70 years: 9.5% decrease. CONCLUSION The introduction of CCTA as a first-line diagnostic test in patients with suspected CCS does not associate with increased use of invasive angiography and seems to have facilitated a more appropriate revascularization practice.
Collapse
Affiliation(s)
- Louise Nissen
- Department of Cardiology, Regional Hospital West Jutland, Gl. landevej 61, 7400 Herning, Denmark
| | - Simon Winther
- Department of Cardiology, Regional Hospital West Jutland, Gl. landevej 61, 7400 Herning, Denmark.,Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark
| | - Morten Schmidt
- Department of Cardiology, Regional Hospital West Jutland, Gl. landevej 61, 7400 Herning, Denmark.,Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark.,Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, 8200 Aarhus N, Denmark
| | - Niels Peter Rønnow Sand
- Department of Cardiology, University Hospital of Southern Denmark, Finsensgade 35, 6700 Esbjerg, Denmark.,Institute of Regional Health Research, University of Southern Denmark, Finsensgade 35, 6700 Esbjerg, Denmark
| | - Grazina Urbonaviciene
- Department of Cardiology, Regional Hospital of Silkeborg, Falkevej 1A, 8600 Silkeborg, Denmark
| | | | - Martin Kirk Christensen
- Department of Cardiology, Aalborg University Hospital, Reberbansgade 15, 9000 Aalborg, Denmark
| | - Martin Busk
- Department of Cardiology, Regional Hospital of Vejle, Beriderbakken 4, 7100 Vejle, Denmark
| | - Jess Lambrechtsen
- Department of Cardiology, Odense University Hospital, Baagøes Alle 31, 5700 Svendborg, Denmark
| | - Axel Diederichsen
- Department of Cardiology, Regional Hospital West Jutland, Gl. landevej 61, 7400 Herning, Denmark
| | - Frank-Peter Elpert
- Department of Cardiology, Regional Hospital West Jutland, Gl. landevej 61, 7400 Herning, Denmark.,Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark
| | - Erik Lerkevang Grove
- Department of Cardiology, Regional Hospital West Jutland, Gl. landevej 61, 7400 Herning, Denmark.,Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark.,Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, 8200 Aarhus N, Denmark
| | - Hans Erik Bøtker
- Department of Cardiology, Regional Hospital West Jutland, Gl. landevej 61, 7400 Herning, Denmark.,Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark.,Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, 8200 Aarhus N, Denmark
| | - Morten Bøttcher
- Department of Cardiology, Regional Hospital West Jutland, Gl. landevej 61, 7400 Herning, Denmark
| |
Collapse
|
5
|
Djaïleb L, Riou L, Piliero N, Carabelli A, Vautrin E, Broisat A, Leenhardt J, Machecourt J, Fagret D, Vanzetto G, Barone-Rochette G, Ghezzi C. SPECT myocardial ischemia in the absence of obstructive CAD: Contribution of the invasive assessment of microvascular dysfunction. J Nucl Cardiol 2018; 25:1017-1022. [PMID: 29209950 DOI: 10.1007/s12350-017-1135-1] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2017] [Revised: 11/02/2017] [Indexed: 11/28/2022]
Abstract
Coronary microvascular dysfunction has recently emerged as a major independent prognostic factor and can be invasively assessed by coronary flow reserve (CFR) and the index of microvascular resistance (IMR). The incremental prognostic value of myocardial ischemia from SPECT myocardial perfusion imaging (MPI) over clinical characteristics, cardiac risk factors, and stress test data for the prediction of hard cardiac events (myocardial infarction and cardiac death) has been well demonstrated over the last two decades regardless of the absence or presence of epicardial CAD. Recently developed semi-conductor, cardiac-dedicated cameras allow for decreased acquisition times and systematic procubitus and decubitus acquisitions thereby limiting the occurrence of false positives historically attributable to artefactual motion, attenuation, and digestive artifacts. It is therefore likely that pathophysiological causes rather than acquisition artifacts might underlie SPECT perfusion abnormalities. Here, we report four representative examples of patients presenting with ischemia in the setting of no obstructive CAD and normal fractional flow reserve together with elevated IMR and low CFR. The results indicate that ischemia from SPECT MPI could result from microvascular dysfunction in patients without obstructive CAD and should be considered as a prognostic factor for hard cardiac events.
Collapse
Affiliation(s)
- Loïc Djaïleb
- INSERM, U1039, Radiopharmaceutiques Biocliniques, Grenoble-Alpes University, Grenoble, France.
- Nuclear Medicine Department, Grenoble-Alpes University Hospital (CHUGA), Avenue Maquis du Grésivaudan, 38700, Grenoble, France.
| | - Laurent Riou
- INSERM, U1039, Radiopharmaceutiques Biocliniques, Grenoble-Alpes University, Grenoble, France
- Grenoble-Alpes University, Grenoble, France
| | - Nicolas Piliero
- INSERM, U1039, Radiopharmaceutiques Biocliniques, Grenoble-Alpes University, Grenoble, France
- Cardiology Department, Grenoble-Alpes University Hospital, Grenoble, France
| | - Adrien Carabelli
- INSERM, U1039, Radiopharmaceutiques Biocliniques, Grenoble-Alpes University, Grenoble, France
- Cardiology Department, Grenoble-Alpes University Hospital, Grenoble, France
| | - Estelle Vautrin
- Nuclear Medicine Department, Grenoble-Alpes University Hospital (CHUGA), Avenue Maquis du Grésivaudan, 38700, Grenoble, France
- Cardiology Department, Grenoble-Alpes University Hospital, Grenoble, France
| | - Alexis Broisat
- INSERM, U1039, Radiopharmaceutiques Biocliniques, Grenoble-Alpes University, Grenoble, France
- Grenoble-Alpes University, Grenoble, France
| | - Julien Leenhardt
- Nuclear Medicine Department, Grenoble-Alpes University Hospital (CHUGA), Avenue Maquis du Grésivaudan, 38700, Grenoble, France
| | - Jacques Machecourt
- Cardiology Department, Grenoble-Alpes University Hospital, Grenoble, France
| | - Daniel Fagret
- INSERM, U1039, Radiopharmaceutiques Biocliniques, Grenoble-Alpes University, Grenoble, France
- Nuclear Medicine Department, Grenoble-Alpes University Hospital (CHUGA), Avenue Maquis du Grésivaudan, 38700, Grenoble, France
| | - Gerald Vanzetto
- INSERM, U1039, Radiopharmaceutiques Biocliniques, Grenoble-Alpes University, Grenoble, France
- Cardiology Department, Grenoble-Alpes University Hospital, Grenoble, France
| | - Gilles Barone-Rochette
- INSERM, U1039, Radiopharmaceutiques Biocliniques, Grenoble-Alpes University, Grenoble, France
- Cardiology Department, Grenoble-Alpes University Hospital, Grenoble, France
| | - Catherine Ghezzi
- INSERM, U1039, Radiopharmaceutiques Biocliniques, Grenoble-Alpes University, Grenoble, France
- Grenoble-Alpes University, Grenoble, France
| |
Collapse
|